Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

被引：57

作者：

Messer, Shawn A. ^{[1
]}

Moet, Gary J. ^{[1
]}

Kirby, Jeffrey T. ^{[1
]}

Jones, Ronald N. ^{[1
,2
]}

机构：

[1] JMI Labs, N Liberty, IA USA

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2009年 / 47卷 / 06期

关键词：

INTERNATIONAL SURVEILLANCE; QUALITY-CONTROL; FLUCONAZOLE; CASPOFUNGIN;

D O I：

10.1128/JCM.02434-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Results from the SENTRY international fungal surveillance program for 2006 to 2007 are presented. A total of 1,448 Candida sp., 49 Aspergillus fumigatus, and 33 Cryptococcus neoformans isolates were obtained from infected sterile-site sources in patients on five continents. Reference susceptibility was determined for anidulafungin, caspofungin, 5-flucytosine, fluconazole, itraconazole, posaconazole, voriconazole, and amphotericin B by CLSI methods.

引用

页码：1942 / 1946

页数：5

共 17 条

[1]

[Anonymous], 2008, APPROVED STANDARD M3

[2]

[Anonymous], 2008, Approved standard M27-A. A National Committee for Clinical Laboratory Standards

[3]

CLSI, 2008, M27S3 CLSI

[4] Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds [J].